Outcomes of ulcerative colitis-associated dysplasia patients referred for potential endoscopic submucosal dissection.
Dong-Hoon YangJihun KimEun Mi SongKiju ChangSun-Ho LeeSung Wook HwangSang Hyoung ParkByong Duk YeSeung Wook HongSeung-Jae MyungSuk-Kyun YangPublished in: Journal of gastroenterology and hepatology (2019)
Endoscopic submucosal dissection is a feasible endoscopic treatment option for UC-associated dysplasia showing noninvasive pit or vascular patterns, no surface ulceration, distinct borders, and appropriate lifting after submucosal injection. Meticulous endoscopic surveillance is essential to monitor for local or metachronous recurrence of dysplasia after ESD.